Concepedia
Statistics
Publications
9
Citations
1.7K
H-Index
Active since
2011
Affiliations
University of Cambridge(Current)
Roslin Institute
Nottingham University Hospitals NHS Trust
University of Manchester
Intensive Care National Audit & Research Centre
Katherine Gillespie is an author at University of Cambridge specializing in pharmacotherapy, 28-day mortality, and clinical trials.
Publications per year
2011–2024
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Beyond Consent: Building Trusting Relationships With Diverse Populations in Precision Medicine Research
Stephanie A. Kraft, Mildred K. Cho, Katherine Gillespie et al. · The American Journal of Bioethics · 2018 · 274 citations
Management, Translational Sciences, Medical Ethics +15
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
1–5 of 9